Showing results (111-120 of 451) with videos related to
Sort By:
Pageof 46
BMJ (Clinical Research Ed.)|November 14, 2006
Lifetime cost effectiveness of simvastatin in a range of risk groups and age groups derived from a randomised trial of 20,536 people, Borislava Mihaylova, Andrew Briggs, et al.Lancet (London, England)|May 25, 2005
Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individualsBorislava Mihaylova, Andrew Briggs, Jane Armitage, et al.Lancet (London, England)|March 6, 2004
Four paraoxonase gene polymorphisms in 11212 cases of coronary heart disease and 12786 controls: meta-analysis of 43 studiesJeremy G Wheeler, Bernard D Keavney, Hugh Watkins, et al.Trials|August 16, 2024
Towards an understanding of the ethics of electronic consent in clinical trialsKatherine Sahan, Rohan Wijesurendra, David Preiss, et al.Clinical Journal of the American Society of Nephrology : CJASN|December 14, 2019
Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKDJulio Alejandro Lamprea-Montealegre, Natalie Staplin, William G Herrington, et al.The Lancet. Gastroenterology & Hepatology|January 17, 2021
Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based studyEva J A Morris, Raphael Goldacre, Enti Spata, et al.Heart (British Cardiac Society)|October 3, 2022
Population-wide cohort study of statin use for the secondary cardiovascular disease prevention in Scotland in 2009-2017Inna Thalmann, David Preiss, Iryna Schlackow, et al.BMJ Quality & Safety|September 29, 2023
Quality of care for secondary cardiovascular disease prevention in 2009-2017: population-wide cohort study of antiplatelet therapy use in ScotlandInna Thalmann, David Preiss, Iryna Schlackow, et al.Obesity (Silver Spring, Md.)|March 5, 2023
Metabolic profiling of MRI-measured liver fat in the UK BiobankLouisa Gnatiuc Friedrichs, Eirini Trichia, Diego Aguilar-Ramirez, et al.Journal of Hypertension|March 13, 2024
A blunted nocturnal blood pressure decline is associated with all-cause and cardiovascular mortalityAlejandro de la Sierra, Natalie Staplin, Luis M Ruilope, et al.Pageof 46